Skip to main content
Xvivo Perfusion logo

Xvivo Perfusion — Investor Relations & Filings

Ticker · XVIVO ISIN · SE0004840718 LEI · 549300G2464FYLS14B41 ST Manufacturing
Filings indexed 286 across all filing types
Latest filing 2017-02-08 Management Reports
Country SE Sweden
Listing ST XVIVO

About Xvivo Perfusion

https://www.xvivogroup.com/

Xvivo Perfusion is a medical technology company specializing in ex-vivo organ preservation for transplantation. The company develops machine perfusion technologies, solutions, and services designed to extend the life of major organs, including lungs, livers, and kidneys. Its core technology, organ perfusion, is an alternative to static cold storage that continuously supplies an organ with an oxygenated solution while it is outside the body. This process helps support cellular function, prevent tissue damage, and allows clinicians to assess organ viability prior to transplant. The company's objective is to increase organ utilization, extend preservation times, and improve patient outcomes. Key products include the XPS™ for lung perfusion, Liver Assist™, Kidney Assist Transport™, and the PERFADEX® Plus solution for lung preservation.

Recent filings

Filing Released Lang Actions
Management Reports 2017
Management Reports Classification · 99% confidence The document is titled "REPORT ON OPERATIONS 2016 XVIVO PERFUSION AB (PUBL)" and contains detailed financial results for the full year 2016 (Jan – Dec) and the fourth quarter (Oct - Dec), including Net Sales, EBITDA, Operating Income, and Net Income, along with management commentary and outlook. This structure, covering a full fiscal year and providing comprehensive financial statements (even if summarized in tables), strongly indicates an Annual Report. Although the title uses 'Report on Operations', the content depth and period covered (full year) align best with the definition of a 10-K, which is the official yearly report covering full financial performance. It is not merely an Earnings Release (ER) as it is comprehensive, nor an Interim Report (IR) as it covers the full year. Since the document is very long (80k+ characters) and contains the full financial details, it is classified as the report itself, not an announcement of the report (RPA/RNS).
2017-02-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.